Stay updated on BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.

Latest updates to the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference9%
- Check19 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); the Back to Top element was removed, a minor UI change.SummaryDifference0.5%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.5%
- Check47 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. These changes enhance the clarity of the page's content regarding the study's location.SummaryDifference59%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.